Institute of Health and
Biomedical Innovation

Commercialisation

We bring the benefits of our research discoveries to the community and global marketplace by working with bluebox, QUT's knowledge transfer and innovation company. This includes protecting intellectual property, creating, licensing agreements, commercial discussions with industry partners and establishing start-up companies.

Several successful companies have formed out of QUT-developed intellectual property (IP), including:

  • Tissue Therapies Ltd, using key technologies in novel growth factors and autologous cell therapies
  • ImpediMed Ltd, a medical device company focusing on bioimpedance
  • AdAlta, using a platform-technology approach to develop novel antibody and peptide-based therapeutics against select targets.